GMO news related to New Zealand

08.01.2007 |

ArborGen, Scion sign deal to benefit global forestry, develop new bio-based products

ArborGen LLC and Crown Research Institute Scion of New Zealand have signed a multi-million dollar partnership deal in a move that will build significant biomaterials expertise and benefit the productivity of plantation forestry worldwide. ArborGen based in Summerville, S.C., and Scion, based in Rotorua, New Zealand, have signed a research and development agreement to focus on the areas of gene discovery and molecular breeding for forest trees.